Evaluation of 12 commercial tests for detection of Epstein-Barr virus- specific and heterophile antibodies

Clinical and Diagnostic Laboratory Immunology

Volumn 7, Issue 3, 2000, Pages 451-456

  Bruu, Anne Lise ^a   Hjetland, Reidar ^b   Holter, Ellen ^c   Mortensen, Liisa ^d   Natås, Olav ^e   Petterson, Wenche ^f   Skar, Anne Grete ^g   Skarpaas, Tone ^h   Tjade, Trygve ⁱ   Åsjø, Birgitta ^j  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b Department of Microbiology   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

^d NORDLAND HOSPITAL   (Norway)

^e STAVANGER UNIVERSITY HOSPITAL   (Norway)

^f Vestfold Central Hospital   (Norway)

^g ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^h Vest Agder Central Hospital   (Norway)

ⁱ AKERSHUS UNIVERSITY HOSPITAL   (Norway)

^j HAUKELAND UNIVERSITY HOSPITAL   (Norway)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HETEROPHILE ANTIBODY; VIRUS ANTIBODY;

ANTIBODY DETECTION; ARTICLE; CLINICAL LABORATORY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST; EPSTEIN BARR VIRUS; HUMAN; INFECTIOUS MONONUCLEOSIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SEROLOGY;

EID: 0034098782     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.7.3.451-456.2000     Document Type: Article

References (8)

1. Aalto, S. M., K. Linnavuori, H. Peltola, E. Vuori, B. Weissbrich, J. Schubert, L. Hedman, and K. Hedman. 1998. Immunoreactivation of Epstein-Barr virus due to cytomegalovirus primary infection. J. Med. Virol. 56:186-191.
2. Elgh, F., and M. Linderholm. 1996. Evaluation of six commercially available kits using purified heterophile antigen for the rapid diagnosis of infectious mononucleosis compared with Epstein-Barr virus-specific serology. Clin. Diagn. Virol. 7:17-21.
3. Hofmann, H., and T. Popow-Kraupp. 1994. Diagnosis of EBV infection by means of ELISA. Serodiagn. Immunother. Infect. Dis. 6:135-139.
4. Høiby, E. A., T. Tjade, and O. J. Røtterud. 1985. Evaluation of ten commercial heterophile antibody tests for infectious mononucleosis. APMIS 93:145-151.
5. Hornef, M. W., G. Bein, L. Fricke, J. Steinhoff, H.-J. Wagner, W. Hinderer, H.-H. Sonneborn, and H. Kirchner. 1995. Coincidence of Epstein-Barr virus reactivation, cytomegalovirus infection, and rejection episodes in renal transplant recipients. Transplantation 60:474-480.
6. Obel, N., M. Høier-Madsen, and H. Kangro. 1996. Serological and clinical findings in patients with serological evidence of reactivated Epstein-Barr virus infection. APMIS 104:424-428.
7. Sumara, C. V. 1986. Epstein-Barr virus serologic testing: diagnostic indications and interpretations. Pediatr. Infect. Dis. 5:337-342.
8. Svahn, A., M. Magnusson, L. Jägdahl, L. Schloss, G. Kahlmeter, and A. Linde. 1997. Evaluation of three commercial enzyme-linked immunosorbent assays and two latex agglutination assays for diagnosis of primary Epstein-Barr virus infection. J. Clin. Microbiol. 35:2728-2732.